Skip to main content
Article
Managing Chronic Kidney Disease With MTM
U.S. Pharmacist
  • Samuel N. John, Philadelphia College of Osteopathic Medicine
  • Candis McGraw-Senat, Philadelphia College of Osteopathic Medicine
  • Drew Cates, Philadelphia College of Osteopathic Medicine
  • Melissa Williams, Philadelphia College of Osteopathic Medicine
  • Hiral Gandhi, Philadelphia College of Osteopathic Medicine
Document Type
Article
Publication Date
6-16-2017
Abstract

Incorporating pharmacists into multidisciplinary teams in the outpatient ambulatory care and inpatient acute care settings can circumvent major drug-related problems through the process of medication therapy management (MTM), in which the pharmacist’s care plan includes optimal evidence-based medication, goals of therapy, and, most important, ensuring that appropriate follow-up is carried out. Chronic kidney disease (CKD) patients present with comorbid disease states with often-complex pharmacotherapeutic regimens that can be difficult not only for the patient, but for the prescribers as well. This review evaluates medication-related problems associated with CKD, nonadherence issues, medication reconciliation, and the contributions pharmacists provide through MTM.

Comments

This article was published in U.S. Pharmacist, Volume 42, Issue 6, Pages 29-31.

The published version is available at https://www.uspharmacist.com/article/managing-chronic-kidney-disease-with-mtm.

Copyright © 2017.

Citation Information
Samuel N. John, Candis McGraw-Senat, Drew Cates, Melissa Williams, et al.. "Managing Chronic Kidney Disease With MTM" U.S. Pharmacist Vol. 42 Iss. 6 (2017) p. 29 - 31
Available at: http://works.bepress.com/candis-mcgraw/1/